Piper Jaffray Upgrades Amgen (AMGN) to Overweight
Tweet Send to a FriendGet Alerts AMGN Hot Sheet
Price: $104.24 +2.02%
Rating Summary:
12 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 6
Rating Summary:
12 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 6
Trade AMGN Now!
Piper Jaffray upgraded Amgen (NASDAQ: AMGN) from Neutral to Overweight.
Amgen reported Q2 results Thursday afternoon. The stock is up 4 percent to $82.50 Friday morning.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Amgen reported Q2 results Thursday afternoon. The stock is up 4 percent to $82.50 Friday morning.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- UPDATE: Intuit, Inc. (INTU) Tops Q3 EPS by 4c, Offers Guidance
- Goldman Sachs Upgrades Meritor (MTOR) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Piper Jaffray, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
